The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Open accessAbstract
Engineering T cells to treat autoimmunity: Autoimmune diseases such as lupus and rheumatoid arthritis lack therapies that specifically target only the disease-causing cells. Inspired by the clinical success of using chimeric antigen receptor T cells to treat certain types of cancers, Ellebrecht et al. asked whether a similar approach might also work against antibody-driven autoimmune diseases. They engineered T cells to express chimeric receptors consisting of the disease-causing autoantigen desmoglein 3 fused to signaling domains that activate T cells. When given to diseased mice, the engineered T cells targeted and killed B cells that express antibodies targeting desmoglein 3, hinting that such a strategy may be an effective way to treat antibody-driven autoimmune diseases. Science , this issue p. 179
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (1999) · Science · doi:10.1126/science.285.5425.221 · Cited by 3,102
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Turtle, C. J., Hanafi, L.-A., Berger, C., Gooley, T. A., Cherian, S., Hudecek, M., Sommermeyer, D., Melville, K., Pender, B., Budiarto, T. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85309 · Cited by 2,112
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Three-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968
Long, A. H., Haso, W. M., Shern, J. F., Wanhainen, K. M., Murgai, M., Ingaramo, M., Smith, J. P., Walker, A. J., Kohler, M. E., Venkateshwara, V. R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3838 · Cited by 1,815
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Kochenderfer, J. N., Dudley, M. E., Kassim, S. H., Somerville, R. P. T., Carpenter, R. O., Stetler-Stevenson, M., Yang, J. C., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2025 · Cited by 1,595
Brentjens, R. J., Rivière, I., Park, J. H., Davila, M. L., Wang, X., Stefanski, J., Taylor, C., Yeh, R., Bartido, S., Borquez-Ojeda, O., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348540 · Cited by 1,286
Milone, M. C., Fish, J. D., Carpenito, C., Carroll, R. G., Binder, G. K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.83 · Cited by 1,197
Self-citationSavoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., Kamble, R. T., Bollard, C. M., Gee, A. P., Mei, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46110 · Cited by 1,023
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., Hellström, K. E., Mittler, R. S., & Chen, L. (1997) · Nature Medicine · doi:10.1038/nm0697-682 · Cited by 898
Varma, R., Campi, G., Yokosuka, T., Saito, T., & Dustin, M. L. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.010 · Cited by 879
Zhao, Z., Condomines, M., van der Stegen, S. J. C., Perna, F., Kloss, C. C., Gunset, G., Plotkin, J., & Sadelain, M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.004 · Cited by 843
The kinetic-segregation model: TCR triggering and beyond
Davis, S. J., & van der Merwe, P. A. (2006) · Nature Immunology · doi:10.1038/ni1369 · Cited by 561
Hudecek, M., Lupo-Stanghellini, M.-T., Kosasih, P. L., Sommermeyer, D., Jensen, M. C., Rader, C., & Riddell, S. R. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0330 · Cited by 544
Cruz, C. R. Y., Micklethwaite, K. P., Savoldo, B., Ramos, C. A., Lam, S., Ku, S., Diouf, O., Liu, E., Barrett, A. J., Ito, S., et al. (2013) · Blood · doi:10.1182/blood-2013-06-506741 · Cited by 508
Engineering CAR-T cells: Design concepts
Srivastava, S., & Riddell, S. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.004 · Cited by 485
Johnson, L. A., Scholler, J., Ohkuri, T., Kosaka, A., Patel, P. R., McGettigan, S. E., Nace, A. K., Dentchev, T., Thekkat, P., Loew, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4963 · Cited by 454
Self-citationT-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand
Choudhuri, K., Wiseman, D., Brown, M. H., Gould, K., & van der Merwe, P. A. (2005) · Nature · doi:10.1038/nature03843 · Cited by 371
Biophysical mechanism of T-cell receptor triggering in a reconstituted system
James, J. R., & Vale, R. D. (2012) · Nature · doi:10.1038/nature11220 · Cited by 323
Tsunoda, K., Ota, T., Aoki, M., Yamada, T., Nagai, T., Nakagawa, T., Koyasu, S., Nishikawa, T., & Amagai, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2170 · Cited by 313
The molecular architecture of cadherins in native epidermal desmosomes
Al-Amoudi, A., Díez, D. C., Betts, M. J., & Frangakis, A. S. (2007) · Nature · doi:10.1038/nature05994 · Cited by 278
Colliou, N., Picard, D., Caillot, F., Calbo, S., Le Corre, S., Lim, A., Lemercier, B., Le Mauff, B., Maho-Vaillant, M., Jacquot, S., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005166 · Cited by 249
Linking molecular affinity and cellular specificity in cadherin-mediated adhesion
Katsamba, P., Carroll, K., Ahlsen, G., Bahna, F., Vendome, J., Posy, S., Rajebhosale, M., Price, S., Jessell, T. M., Ben-Shaul, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905349106 · Cited by 242
Payne, A. S., Ishii, K., Kacir, S., Lin, C., Li, H., Hanakawa, Y., Tsunoda, K., Amagai, M., Stanley, J. R., & Siegel, D. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524185 · Cited by 234
Self-citationJonnalagadda, M., Mardiros, A., Urak, R., Wang, X., Hoffman, L. J., Bernanke, A., Chang, W.-C., Bretzlaff, W., Starr, R., Priceman, S., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.208 · Cited by 204
Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
Di Zenzo, G., Di Lullo, G., Corti, D., Calabresi, V., Sinistro, A., Vanzetta, F., Didona, B., Cianchini, G., Hertl, M., Eming, R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64413 · Cited by 174
Self-citationGene therapy for cancer using single-chain Fv fragments specific for 4-1BB
Ye, Z., Hellström, I., Hayden-Ledbetter, M. S., Dahlin, A., Ledbetter, J. A., & Hellström, K. E. (2002) · Nature Medicine · doi:10.1038/nm0402-343 · Cited by 156
Wang, E., Wang, L.-C., Tsai, C., Bhoj, V. G., Gershenson, Z., Moon, E. K., Newick, K., Sun, J., Lo, A., Baradet, T. C., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0054 · Cited by 115
Self-citationPersistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years
Hammers, C. M., Chen, J., Lin, C., Kacir, S., Siegel, D. L., Payne, A. S., & Stanley, J. R. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.291 · Cited by 110
Self-citationSchodin, B. A., Tsomides, T. J., & Kranz, D. M. (1996) · Immunity · doi:10.1016/s1074-7613(00)80490-2 · Cited by 108
Duffy, S., Tsao, K.-L. C., & Waugh, D. S. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2770 · Cited by 76
Ohyama, B., Nishifuji, K., Chan, P. T., Kawaguchi, A., Yamashita, T., Ishii, N., Hamada, T., Dainichi, T., Koga, H., Tsuruta, D., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.448 · Cited by 74
Hassan, R., Lerner, M. R., Benbrook, D. M., Lightfoot, S. A., Brackett, D. J., Wang, Q.-C., & Pastan, I. H. (2002) · PubMed · Cited by 70
Hooijberg, E., Bakker, A. Q., Ruizendaal, J. J., & Spits, H. (2000) · Blood · doi:10.1182/blood.v96.2.459 · Cited by 65
Enrichment of total serum IgG4 in patients with pemphigus
Funakoshi, T., Lunardon, L., Ellebrecht, C. T., Nagler, A. R., O’Leary, C. E., & Payne, A. S. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11144.x · Cited by 63
Self-citationMAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris
Mao, X., Li, H., Sano, Y., Gaestel, M., Park, J. M., & Payne, A. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.224 · Cited by 61
Self-citationRole of transmembrane domains in assembly and intracellular transport of the CD8 molecule.
Hennecke, S., & Cosson, P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74355-5 · Cited by 60
Barrett, D. M., Seif, A. E., Carpenito, C., Teachey, D. T., Fish, J. D., June, C. H., Grupp, S. A., & Reid, G. S. D. (2011) · Blood · doi:10.1182/blood-2011-04-346528 · Cited by 56
Functional reconstitution of an immunoglobulin antigen receptor in T cells.
Costa, T. E., Franke, R. R., Sanchez, M., Misulovin, Z., & Nussenzweig, M. C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.6.1669 · Cited by 51
Yang, S., Yang, Y., Raycraft, J., Zhang, H., Kanan, S., Guo, Y., Ronai, Z. A., Hellström, I., & Hellström, K. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400880101 · Cited by 43
Targeting Pemphigus Autoantibodies through their Heavy-Chain Variable Region Genes
Payne, A. S., Siegel, D. L., & Stanley, J. R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700790 · Cited by 30
Self-citationBerberian, L., Valles‐Ayoub, Y., Gordon, L. K., Targan, S. R., & Braun, J. G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3756 · Cited by 28
Cited by
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Therapeutic T cell engineering
Sadelain, M., Rivière, I., & Riddell, S. (2017) · Nature · doi:10.1038/nature22395 · Cited by 879
The multiple pathways to autoimmunity
Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590
Metadata
- Authors
- Ellebrecht, C. T., Bhoj, V. G., Nace, A., Choi, E. J., Mao, X., Cho, M. J., Di Zenzo, G., Lanzavecchia, A., Seykora, J. T., Cotsarelis, G., Milone, M. C., & Payne, A. S.
- Venue
- Science
- Published
- 2016-07-08
- Volume
- 353
- Issue
- 6295
- Pages
- 179-184
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2473078810
- Cited by
- 738
- References
- 47
- FWCI
- 25.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.